{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T15:10:31Z","timestamp":1779289831639,"version":"3.51.4"},"reference-count":43,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.ophtha.2014.04.042","type":"journal-article","created":{"date-parts":[[2014,6,18]],"date-time":"2014-06-18T07:33:09Z","timestamp":1403076789000},"page":"1877-1884","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":99,"title":["Evaluation of the Long-Term Efficacy and Safety of Infliximab Treatment for Uveitis in Beh\u00e7et's Disease"],"prefix":"10.1016","volume":"121","author":[{"given":"Masaru","family":"Takeuchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Kezuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunao","family":"Sugita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Keino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Namba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshikatsu","family":"Kaburaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuichi","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Nakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuniaki","family":"Hijioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Etsuko","family":"Shibuya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Komae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junko","family":"Hori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Ohguro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koh-hei","family":"Sonoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhisa","family":"Mizuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annabelle A.","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuro","family":"Ishibashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Goto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manabu","family":"Mochizuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2014.04.042_bib1","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/00005792-197505000-00001","article-title":"Behcet's disease. Report of 41 cases and a review of the literature","volume":"54","author":"Chajek","year":"1975","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ophtha.2014.04.042_bib2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-4362.1984.tb05658.x","article-title":"Behcet's disease","volume":"23","author":"Wong","year":"1984","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.ophtha.2014.04.042_bib3","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1056\/NEJM199910213411707","article-title":"Behcet's disease","volume":"341","author":"Sakane","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ophtha.2014.04.042_bib4","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/0-306-48382-3_16","article-title":"The change of clinical manifestations of patients with Behcet's disease in Japan","volume":"528","author":"Kotake","year":"2003","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.ophtha.2014.04.042_bib5","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.ophtha.2003.07.018","article-title":"Comparison of patients with Behcet's disease in the 1980s and 1990s","volume":"111","author":"Yoshida","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2014.04.042_bib6","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1001\/archopht.1970.00990040453009","article-title":"The rate of visual loss in Behcet's disease","volume":"84","author":"Mamo","year":"1970","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.04.042_bib7","first-page":"225","article-title":"The eighth Frederick H. Verhoeff Lecture. Presented by Saiichi Mishima, MD. Behcet's disease in Japan: ophthalmologic aspects","volume":"77","author":"Mishima","year":"1979","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.ophtha.2014.04.042_bib8","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1076\/0927-3948(200009)831-KFT141","article-title":"Behcet's disease in Japan and in Great Britain: a comparative study","volume":"8","author":"Muhaya","year":"2000","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.ophtha.2014.04.042_bib9","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/art.1780400425","article-title":"Azathioprine in Behcet's syndrome: effects on long-term prognosis","volume":"40","author":"Hamuryudan","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ophtha.2014.04.042_bib10","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ajo.2004.03.022","article-title":"Uveitis in Behcet disease: an analysis of 880 patients","volume":"138","author":"Tugal-Tutkun","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.04.042_bib11","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1053\/sarh.2001.19819","article-title":"Treatment of Behcet's disease\u2013an update","volume":"30","author":"Kaklamani","year":"2001","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.ophtha.2014.04.042_bib12","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1076\/0927-3948(200006)821-0FT085","article-title":"Drug therapy in Behcet's disease","volume":"8","author":"Okada","year":"2000","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.ophtha.2014.04.042_bib13","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0140-6736(01)05497-6","article-title":"Effect of infliximab on sight-threatening panuveitis in Behcet's disease","volume":"358","author":"Sfikakis","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ophtha.2014.04.042_bib14","first-page":"1362","article-title":"Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Beh\u00e7et's disease with refractory uveoretinitis","volume":"31","author":"Ohno","year":"2004","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.ophtha.2014.04.042_bib15","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1136\/ard.60.6.637","article-title":"Remission of Behcet's syndrome with tumour necrosis factor alpha blocking therapy","volume":"60","author":"Goossens","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ophtha.2014.04.042_bib16","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/S0140-6736(01)06677-6","article-title":"Effect of infliximab on threatening panuveitis in Behcet's disease","volume":"358","author":"Munoz-Fernandez","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ophtha.2014.04.042_bib17","first-page":"66","article-title":"Revised diagnostic criteria for Behcet's disease in 1987","volume":"28","author":"Mizushima","year":"1988","journal-title":"Ryumachi"},{"key":"10.1016\/j.ophtha.2014.04.042_bib18","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/s10384-010-0859-0","article-title":"Acquired resistance to infliximab against uveitis due to Behcet's disease after one year of administration","volume":"54","author":"Ito","year":"2010","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.04.042_bib19","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1136\/bjo.2009.158840","article-title":"Comparison of infliximab versus ciclosporin during the initial 6-month treatment period in Behcet disease","volume":"94","author":"Yamada","year":"2010","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.04.042_bib20","first-page":"87","article-title":"Effects and safety of infliximab administration in refractory uveoretinitis with Behcet's disease","volume":"114","author":"Tanaka","year":"2010","journal-title":"Nihon Ganka Gakkai Zasshi"},{"key":"10.1016\/j.ophtha.2014.04.042_bib21","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1136\/bjo.2009.168856","article-title":"Timing of recurrent uveitis in patients with Behcet's disease receiving infliximab treatment","volume":"95","author":"Yamada","year":"2011","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.04.042_bib22","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1136\/bjo.2010.194464","article-title":"Decreased ocular inflammatory attacks and background retinal and disc vascular leakage in patients with Behcet's disease on infliximab therapy","volume":"95","author":"Keino","year":"2011","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.04.042_bib23","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1001\/archophthalmol.2011.2698","article-title":"Multicenter study of infliximab for refractory uveoretinitis in Behcet disease","volume":"130","author":"Okada","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.04.042_bib24","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3109\/09273948.2012.665124","article-title":"Infliximab monotherapy versus infliximab and colchicine combination therapy in patients with Behcet's disease","volume":"20","author":"Takeuchi","year":"2012","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.ophtha.2014.04.042_bib25","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1159\/000329190","article-title":"Clinical course before and after cataract and glaucoma surgery under systemic infliximab therapy in patients with Behcet's disease","volume":"2","author":"Nishida","year":"2011","journal-title":"Case Rep Ophthalmol [serial online]"},{"key":"10.1016\/j.ophtha.2014.04.042_bib26","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s10384-006-0424-z","article-title":"Long-term infliximab treatment for Behcet's disease","volume":"51","author":"Takamoto","year":"2007","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.04.042_bib27","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s10384-012-0182-z","article-title":"Clinical background comparison of patients with and without ocular inflammatory attacks after initiation of infliximab therapy","volume":"56","author":"Yoshida","year":"2012","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.04.042_bib28","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/s00417-011-1908-1","article-title":"Correlation between elevation of serum antinuclear antibody titer and decreased therapeutic efficacy in the treatment of Behcet's disease with infliximab","volume":"250","author":"Iwata","year":"2012","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.04.042_bib29","first-page":"85","article-title":"Infliximab treatment for Behcet's disease\u2013beginning of the biological drug era","volume":"114","author":"Namba","year":"2010","journal-title":"Nihon Ganka Gakkai Zasshi"},{"key":"10.1016\/j.ophtha.2014.04.042_bib30","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1136\/bjo.2009.174888","article-title":"Relationship between serum infliximab levels and acute uveitis attacks in patients with Behcet disease","volume":"95","author":"Sugita","year":"2011","journal-title":"Br J Ophthalmol"},{"issue":"7\u20138","key":"10.1016\/j.ophtha.2014.04.042_bib31","first-page":"260","article-title":"Ocular manifestations in Beh\u00e7et's disease","volume":"49","author":"Hayashi","year":"2006","journal-title":"Japan Med Assoc J"},{"key":"10.1016\/j.ophtha.2014.04.042_bib32","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1093\/rheumatology\/ken298","article-title":"Loss of efficacy during long-term infliximab therapy for sight-threatening childhood uveitis","volume":"47","author":"Simonini","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ophtha.2014.04.042_bib33","doi-asserted-by":"crossref","first-page":"R545","DOI":"10.1186\/ar1715","article-title":"Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey","volume":"7","author":"De Bandt","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.ophtha.2014.04.042_bib34","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/MD.0b013e3181441a68","article-title":"Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases","volume":"86","author":"Ramos-Casals","year":"2007","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ophtha.2014.04.042_bib35","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.clim.2007.08.012","article-title":"TNFalpha blockade in human diseases: an overview of efficacy and safety","volume":"126","author":"Lin","year":"2008","journal-title":"Clin Immunol"},{"key":"10.1016\/j.ophtha.2014.04.042_bib36","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1161\/01.CIR.0000077913.60364.D2","volume":"107","author":"Chung","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ophtha.2014.04.042_bib37","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1111\/j.1365-2133.2008.08851.x","article-title":"The impact of treatment with tumour necrosis factor-alpha antagonists on the course of chronic viral infections: a review of the literature","volume":"159","author":"Domm","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ophtha.2014.04.042_bib38","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1586\/eci.11.6","article-title":"The risk of tuberculosis in patients treated with TNF antagonists","volume":"7","author":"Salgado","year":"2011","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.ophtha.2014.04.042_bib39","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.3899\/jrheum.100995","article-title":"Does anti-tumor necrosis factor-alpha therapy affect risk of serious infection and cancer in patients with rheumatoid arthritis? a review of longterm data","volume":"38","author":"Keystone","year":"2011","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.ophtha.2014.04.042_bib40","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s10792-006-9006-9","article-title":"Long-term safety and efficacy of infliximab therapy in refractory uveitis due to Behcet's disease","volume":"26","author":"Abu El-Asrar","year":"2005","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.04.042_bib41","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s10384-006-0425-y","article-title":"Infliximab treatment for ocular and extraocular manifestations of Behcet's disease","volume":"51","author":"Accorinti","year":"2007","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.04.042_bib42","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1093\/rheumatology\/kem101","article-title":"Long-term efficacy of infliximab in refractory posterior uveitis of Behcet's disease: a 24-month follow-up study","volume":"46","author":"Niccoli","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ophtha.2014.04.042_bib43","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3109\/09273948.2012.670360","article-title":"Long-term efficacy and safety of infliximab in the treatment of Behcet's disease","volume":"20","author":"Capella","year":"2012","journal-title":"Ocul Immunol Inflamm"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642014003960?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642014003960?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T14:05:28Z","timestamp":1758981928000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642014003960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":43,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0161642014003960"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2014.04.042","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718460153.793529300","asserted-by":"object"}]},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the Long-Term Efficacy and Safety of Infliximab Treatment for Uveitis in Beh\u00e7et's Disease","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2014.04.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}